Teosyal Puresense GLOBAL ACTION is a crosslinked hyaluronic acid-based dermal filler meant for administration into the mid dermal layer of the skin; it is designed for medium line correction. Lidocaine is added to Teosyal GLOBAL ACTION so that patient discomfort during treatments will be diminished.
Dermal filler Teosyal GLOBAL ACTION has a moderate level of crosslinking and a medium density; it is a monophasic monodensified filler, so it has good durability. It is used for filling in cutaneous depressions and for treating wrinkles that are not yet very pronounced. Teosyal GLOBAL ACTION has only a modest volumizing capacity, but because hyaluronic acid is outstanding in its ability to attract and retain water in the skin, the filler helps smooth and hydrate skin no matter where it is injected, returning it to a younger-looking state. Outcomes with dermal filler Teosyal GLOBAL ACTION tend to look very natural.
Dermal filler Teosyal GLOBAL ACTION is indicated for correcting moderate facial wrinkles such as glabella lines, perioral lines, and mild-to-moderate nasolabial folds. The product is not recommended for treating tear troughs. Results should be visible the day of the procedure, and although each patient is different, the effects of treatment with Teosyal GLOBAL ACTION last up to nine months.
Dermal filler Teosyal Puresense GLOBAL ACTION is manufactured in Switzerland by Teoxane Laboratories. It is made of crosslinked sodium hyaluronate not of animal origin. Teosyal GLOBAL ACTION comes as two prefilled syringes, each containing 1 ml of gel and is accompanied by one 30G1/2” needle. The concentration of hyaluronic acid is 25 mg/ml, while Lidocaine is present at a concentration of 3 mg/ml.